Low dose bleomycin and methotrexate in cervical cancer.
Publication/Presentation Date
2-1-1976
Abstract
Twenty patients with recurrent and disseminated carcinoma of the cervix were treated with Bleomycin, 10 mg/m2 weekly and Methotrexate, 10 mg/m2 every fourth day. Twelve of the 20 (60%) had a greater than 50% shrinking of measured tumor masses lasting a median remission time of 7.5 months. The data suggest that combination protracted chemotherapy with these drugs of metastatic cervical cancer might improve the outlook of patients with this condition.
Volume
37
Issue
2
First Page
660
Last Page
664
ISSN
0008-543X
Published In/Presented At
Conroy, J. F., Lewis, G. C., Brady, L. W., Brodsky, I., Kahn, S. B., Ross, D., & Nuss, R. (1976). Low dose bleomycin and methotrexate in cervical cancer. Cancer, 37(2), 660–664. https://doi.org/10.1002/1097-0142(197602)37:2<660::aid-cncr2820370208>3.0.co;2-v
Disciplines
Medicine and Health Sciences
PubMedID
56215
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article